Five research papers worth knowing about
For this update, we selected five papers from the PubMed monitoring window of 18 October to 1 November 2026. They address pain after surgery, surgical planning, quality of life, and research on antibiotics and emerging anti-inflammatory approaches. It matters whether a finding comes from an observational study, a narrative review or a questionnaire-validation study: each provides a different kind of evidence, and none is a personalized treatment recommendation.
1. What happens to pain after surgery?
A retrospective study followed 83 people with hidradenitis suppurativa (HS) who underwent local excision of 194 lesions. Their average pain score on a 0–10 scale fell from 6.9 before surgery to 0.9 at six months. The investigators also examined ultrasound findings. The association between differences in palpation and ultrasound assessment and later pain was weak.
What to keep in mind: The findings are encouraging, but there was no randomized comparison group. An average improvement cannot predict how much pain relief any particular person will experience after surgery. Original study, PMID 42929477
2. Matching the operation to the extent of disease
A narrative review explains why surgical techniques should be tailored to persistent tunnelsSinus Tract: A tunnel-like channel under the skin that forms between abscesses or nodules. Sinus tracts indicate more advanced disease and can chronically drain fluid. They are associated with Hurley Stages II and III. and scarring. DeroofingDeroofing: A surgical procedure in which the roof of an abscess or sinus tract is removed so the wound base is exposed and can heal from the inside out. Less invasive than wide local excision, it is often performed on an outpatient basis. may suit localized tunnels, while more extensive disease may call for different approaches. Timing, pre-operative imaging and wound care also matter. The authors discuss how surgery can be combined with medical management.
What to keep in mind: This is a synthesis of existing studies and expert views, not a new controlled trial comparing operations. The choice of procedure requires an individual assessment by an experienced care team. Review, PMID 42904762
3. Measuring quality of life with four questions
The newly developed HiSQOLHiSQoL (Hidradenitis Suppurativa Quality of Life): A 17-item HS-specific quality-of-life questionnaire validated in the late 2010s. More sensitive to HS-specific concerns (drainage, odour, intimacy) than the general DLQI.-mini shortens an established 17-item HS quality-of-life questionnaire to four items covering pain, feeling down or depressed, walking and getting dressed. Its development used clinical-study datasets and input from patient research partners. The authors report good measurement performance for the shortened instrument.
What to keep in mind: This may make conversations about daily-life impact easier. It measures quality of life; it is neither a diagnostic test nor evidence that a particular treatment works. Validation study, PMID 42904579
4. Why might ertapenem help in severe HS?
A review examines intravenous ertapenem, an antibiotic used or studied in selected cases of severe, treatment-refractory HS. In addition to its antimicrobial effects, the authors explore whether it could influence inflammatory signaling. Some mechanistic evidence comes from experimental systems outside HS.
What to keep in mind: A proposed mechanism is not proof of an additional, established anti-inflammatory effect in people with HS. Intravenous broad-spectrum antibiotics require careful clinical consideration, including antibiotic stewardship. Review, PMID 42938736
5. BTK inhibitors: promising biology, uncertain clinical value
Another review explores inhibitors of Bruton tyrosine kinase (BTK) across several inflammatory skin diseases. These medicines alter specific immune-cell signaling pathways. For HS, clinical benefit remains uncertain; the authors call for disease-specific studies and longer-term safety data.
What to keep in mind: A plausible biologicalBiologic: A class of medications derived from living cells that target specific components of the inflammatory process. For Acne Inversa, biologics such as adalimumab and secukinumab are used when other treatments are insufficient. pathway is not the same as evidence of patient benefit. Review, PMID 42942140
Questions to bring to an appointment
These papers may offer useful starting points for discussing your care:
- If I have persistent tunnels, would a surgical assessment be appropriate?
- Are we tracking pain and the impact of HS on everyday activities as well as skin symptoms?
- Which treatments are supported by clinical evidence, and which are still experimental?
Important: This is a curated editorial overview, not a clinically reviewed article or personalized medical advice. Observational studies and reviews cannot determine what is right for an individual. Do not change treatment based on this article without discussing it with a qualified clinician.
Sources
All five papers are linked above and listed in the article’s references. This is a selected reading list, not a comprehensive systematic review.
Terms explained in this article
Quick definitions of the key medical terms. Select any term for its full glossary entry.
- Sinus Tract
- A tunnel-like channel under the skin that forms between abscesses or nodules. Sinus tracts indicate more advanced disease and can chronically drain fluid. They are associated with Hurley Stages II and III.
- Deroofing
- A surgical procedure in which the roof of an abscess or sinus tract is removed so the wound base is exposed and can heal from the inside out. Less invasive than wide local excision, it is often performed on an outpatient basis.
- HiSQoL (Hidradenitis Suppurativa Quality of Life)
- A 17-item HS-specific quality-of-life questionnaire validated in the late 2010s. More sensitive to HS-specific concerns (drainage, odour, intimacy) than the general DLQI.
- Biologic
- A class of medications derived from living cells that target specific components of the inflammatory process. For Acne Inversa, biologics such as adalimumab and secukinumab are used when other treatments are insufficient.
References
- Pain Outcomes after Surgical Excision in Hidradenitis Suppurativa and the Role of Ultrasonography. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2026 — PMID 42929477 · DOI 10.1097/DSS.0000000000005414
- Bruton Tyrosine Kinase Inhibitors in Immune-Mediated Skin Diseases: Current Evidence and Future Directions. International journal of molecular sciences, 2026 — PMID 42942140 · DOI 10.3390/ijms27209375 · PMCID PMC13705118
- Optimizing surgery in hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 — PMID 42904762 · DOI 10.1111/jdv.70768
- HiSQOL-mini: Development and Validation of a Shortened Version of the Hidradenitis Suppurativa Quality of Life (HiSQOL) Instrument. The British journal of dermatology, 2026 — PMID 42904579 · DOI 10.1093/bjd/ljag468
- Ertapenem in Hidradenitis Suppurativa: A Review of Antimicrobial Effects and a Proposed Immunomodulatory Role. Antibiotics (Basel, Switzerland), 2026 — PMID 42938736 · DOI 10.3390/antibiotics15100995 · PMCID PMC13700769